Indications and uses
To relieve the symptoms of boils.
To relieve the symptoms of boils.
Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.
USTILAGO MAIDIS
To relieve the symptoms of boils.
Keep this and all medicines out of reach of children.
Indications:
USTILAGO MAIDIS Boils
If symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.
Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.
Sucrose/Lactose
The OTC potency range of USTILAGO MAIDIS is 3x–30x, 2c–30c, 200c, 1m, 10m, 50m, and CM.
Availability is subject to change.
All WHP single remedies are made to order; thus, the labels are printed on the same label stock as the orders are filled.
‘Bottle Size’ and ‘Potency’ vary on the label depending on customer choice.
Standard bottle sizes for pellet-form remedies are 2 dram, 4 dram, 1 ounce, 2 ounce, and 4 ounce.
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68428-690 | 68428-690-03, 68428-690-05, 68428-690-11, 68428-690-12, 68428-690-06 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SUCROSE | C151H8M554 | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| USTILAGO MAYDIS | 4K7Z7K7SWG | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 01f4f189-608f-4663-e063-6394a90a9564 | eea2c12c-c4bb-47da-9359-e297016541bf | 2023-08-02 | Warnings | eea2c12c-c4bb-47da-9359-e297016541bf |
Adverse event summaries are temporarily unavailable. Other product information remains available.